Chilton Capital Management LLC Procept Bio Robotics Corp Transaction History
Chilton Capital Management LLC
- $2.32 Billion
- Q4 2024
A detailed history of Chilton Capital Management LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Chilton Capital Management LLC holds 125 shares of PRCT stock, worth $8,365. This represents 0.0% of its overall portfolio holdings.
Number of Shares
125
Previous 125
-0.0%
Holding current value
$8,365
Previous $10,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PRCT
# of Institutions
294Shares Held
41.6MCall Options Held
196KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.14MShares$344 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$233 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$117 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA1.49MShares$99.8 Million0.02% of portfolio
-
Loomis Sayles & CO L P1.21MShares$80.8 Million0.12% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.98B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...